Zurich, Switzerland

Gael Luis Boivin

USPTO Granted Patents = 1 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gael Luis Boivin: Innovator in Radiotherapy

Introduction

Gael Luis Boivin is a prominent inventor based in Zurich, Switzerland. He has made significant contributions to the field of radiotherapy, particularly in the treatment of cancer. His innovative approaches aim to enhance the effectiveness of cancer treatments through advanced technology.

Latest Patents

Gael Luis Boivin holds a patent for "Methods of and apparatus for treatment with flash radiotherapy." This patent focuses on ultra-high dose rate radiotherapy (FLASH) for cancer treatment. The apparatus is designed to administer no more than five fractions of proton ultra-high dose rate radiotherapy, with radiation ranging from 1.5 Gy to 60 Gy. The treatment aims to prevent tumor growth for at least 10% longer than standard care, induce greater tumor regression, and delay tumor regrowth by approximately two months longer than conventional methods.

Career Highlights

Throughout his career, Gael has worked with notable organizations, including Varian Medical Systems, Inc. and Aarhus University. His experience in these institutions has allowed him to develop and refine his innovative approaches to cancer treatment.

Collaborations

Gael has collaborated with several professionals in his field, including Ricky Anupam Sharma and Sophia Pfister. These collaborations have contributed to the advancement of his research and the development of effective treatment methods.

Conclusion

Gael Luis Boivin is a key figure in the field of radiotherapy, with a focus on improving cancer treatment through innovative technologies. His work continues to influence the medical community and offers hope for enhanced patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…